Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
about
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersIdentification and characterization of ovarian cancer-initiating cells from primary human tumorsCancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyNovel Action of FSH on Stem Cells in Adult Mammalian Ovary Induces Postnatal Oogenesis and Primordial Follicle AssemblyNanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineAutophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and MetastasisEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachRegulation of ovarian cancer stem cells or tumor-initiating cellsCardiac side population cells: moving toward the center stage in cardiac regenerationCan nanomedicines kill cancer stem cells?Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype.Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENIdentification and characterization of cancer stem cells in canine mammary tumorsNew trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesRegulatory mechanisms of microRNAs in lung cancer stem cellsCancer stem cells: the lessons from pre-cancerous stem cellsSALL4, a novel marker for human gastric carcinogenesis and metastasisDrug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic propertiesWithaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cellsThe Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem CellsOxidative stress, inflammation, and cancer: how are they linked?Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cellsInhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.Advances in complex multiparameter flow cytometry technology: Applications in stem cell research.Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.Persistence of side population cells with high drug efflux capacity in pancreatic cancer.Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cellsCancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelCancer stem cells in solid tumors: elusive or illusive?Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate.Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells.Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometriumVisualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells.Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironmentOvarian cancer stem-like side-population cells are tumourigenic and chemoresistant.Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.Circulating Tumor Cells in Early-Stage Breast Cancer.Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.
P2860
Q21562662-CA3ECCCA-39D0-430E-A3A4-529DA9F41933Q24644329-E1EBA2A9-4701-4FD6-8749-00F2A1B305B3Q26740207-9B77E6D8-8418-45D7-925E-518DC72ADCCAQ26774599-812E8547-1697-4C62-9F21-1F34F511E8F2Q26776095-2CB86757-4D59-4413-8FE1-C75F732E63E9Q26796793-DF30D40C-D4EE-4CC7-BA53-2B399658FD8DQ26849477-62621687-54EA-434D-A342-55FD2BA13941Q26853096-92436F32-0493-41C2-918A-764B1351840CQ26862552-B86ED5D1-E11A-4F53-B3AA-E1CF8B2D3EAEQ27022017-F2A6E10D-0B06-4FCE-BDA2-850AEDF60068Q27314826-7CD4A8DB-4328-4521-A8AB-3BC7B762A3E1Q27335766-5C3569CE-C9E3-44B7-9B40-BD1BFD82CE83Q28067454-1B609AC9-7C16-4F94-BBA5-A7045830960EQ28067499-A08C3400-419F-442E-A388-21D75D076F89Q28072716-04A1F6D9-E263-4D9E-AA5B-8D8B03601187Q28259527-3C159182-75B1-4416-B647-B4ABA5F7DD58Q28302738-662A6CA0-2CF6-408F-BA47-FC79DC248839Q28473512-81911ABD-F436-41E9-A356-359EC407D1CBQ28543359-D2B9E54F-5EB8-4F9F-94F8-000F347ADE36Q28550040-E690A57E-842F-45D2-9129-A009B7821C6FQ29616835-ED2EDC40-C847-47F9-8B55-D97A5056A893Q30435060-2E88F2A1-C5FA-432C-A0D6-97CB297DE1E5Q30478184-D820F9A4-2DF0-4D97-9031-7258E609E1E4Q30479710-909B57DE-501F-4DFF-9E6F-89D93CF1CAAEQ32177089-356A49D5-3DEB-4948-9CD3-473D7D09D710Q33317784-7AE98D06-AECA-48B6-98B5-9C9956492D1BQ33334266-85452FE7-ADA0-4B8E-BF8B-8486149F563EQ33338039-7D0E8848-2A6C-4A0B-9985-9859D229BF52Q33349066-4F0BC234-BC1E-412B-9DD5-58AE30DB1155Q33370714-27B51C79-AFFF-482A-90A5-7F7F12E80464Q33415974-51C6C4F7-B9A3-4638-B250-54F9A41D2921Q33479192-A56B8A3F-A8C8-4698-BC3F-82271196021CQ33508776-BD732ACE-3D2A-4156-A6A3-A20438E9F4ACQ33516216-3EDF9BC5-83BA-4A99-9DF1-8F20FCAD3113Q33521161-4C028E15-E48A-44AD-9530-31B676FD308CQ33534069-E7106176-92CC-45BA-B922-DCAC52AABC25Q33547790-A299351A-BCEA-4099-842C-82A43126F699Q33559560-E049DAAC-6369-414B-869B-CEE6CD6258EFQ33579111-330FBADB-8172-4E23-8412-6D988D67770DQ33587316-6DDCDC1A-7656-419E-AF92-63328E5E96EB
P2860
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ovarian cancer side population ...... iting Substance responsiveness
@ast
Ovarian cancer side population ...... iting Substance responsiveness
@en
type
label
Ovarian cancer side population ...... iting Substance responsiveness
@ast
Ovarian cancer side population ...... iting Substance responsiveness
@en
prefLabel
Ovarian cancer side population ...... iting Substance responsiveness
@ast
Ovarian cancer side population ...... iting Substance responsiveness
@en
P2093
P2860
P356
P1476
Ovarian cancer side population ...... iting Substance responsiveness
@en
P2093
Daniela M Dinulescu
David Dombkowski
David T Maclaughlin
Denise Connolly
Frederic Preffer
Patricia K Donahoe
Paul P Szotek
Peter T Masiakos
Rafael Pieretti-Vanmarcke
Rosemary Foster
P2860
P304
11154-11159
P356
10.1073/PNAS.0603672103
P407
P577
2006-07-18T00:00:00Z